Horsham, United Kingdom

Michael J Crimmin

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignee: Beecham Group Plc. Active years: 1984-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael J Crimmin. Retrieved from https://idiyas.com/inventor/michael-j-crimmin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1984-1991

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Michael J Crimmin: Innovator in Antibacterial Compounds

Introduction

Michael J Crimmin is a notable inventor based in Horsham, GB. He has made significant contributions to the field of antibacterial compounds, holding a total of 4 patents. His work focuses on developing innovative solutions to combat bacterial and mycoplasmal infections.

Latest Patents

Among his latest patents are the antibacterial monic acid derivatives, which have been prepared to exhibit antibacterial and/or antimycoplasmal activity. Additionally, he has developed antibacterial 1-normon-2-yl-heterocyclic compounds, characterized by a 5-membered heterocyclic group that possesses a 6-.pi.electron system.

Career Highlights

Michael J Crimmin has had a distinguished career, primarily working with Beecham Group Plc. His research and inventions have contributed to advancements in the pharmaceutical industry, particularly in the development of effective antibacterial agents.

Collaborations

Throughout his career, he has collaborated with esteemed colleagues such as Norman H Rogers and Peter J O'Hanlon, further enhancing the impact of his work in the field.

Conclusion

Michael J Crimmin's innovative contributions to antibacterial compounds highlight his role as a significant inventor in the pharmaceutical industry. His patents reflect a commitment to addressing critical health challenges through scientific innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…